Primary lateral sclerosis natural history study – planning, designing, and early enrollment

References

• Statland JM, Barohn RJ, Dimachkie MM, Floeter MK, Mitsumoto H. Primary lateral sclerosis. Neurol Clin. 2015;33:749–60.
   PubMed Web of Science ®Google Scholar
• Barohn RJ, Fink JK, Heiman-Patterson T, Huey ED, Murphy J, Statland JM, et al. The clinical spectrum of primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:3–10.
   PubMed Web of Science ®Google Scholar
• Turner MR, Talbot K. Primary lateral sclerosis: diagnosis and management. Pract Neurol. 2020; Aug20:262–9.
   PubMedGoogle Scholar
• Mitsumoto H, Turner MR, Ajroud-Driss S, Andres P, Andrews J, Gomez EA, all Delegates of the PLS Conference, et al. Preface: promoting research in PLS: current knowledge and future challenges. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:1–2.
   PubMed Web of Science ®Google Scholar
• Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 1992;115: 495–520.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Cheng B, Katz IB, Pinto M, Hays AP, Mitsumoto H, et al. The natural history of primary lateral sclerosis. Neurology 2006;66:647–53.
   PubMed Web of Science ®Google Scholar
• Gordon PH, Cheng B, Katz IB, Mitsumoto H, Rowland LP. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Neurology 2009; 72:1948–52.
   PubMed Web of Science ®Google Scholar
• Floeter MK, Warden D, Lange D, Wymer J, Paganoni S, Mitsumoto H. Clinical care and therapeutic trials in PLS. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:67–73.
   PubMed Web of Science ®Google Scholar
• Turner MR, Barohn RJ, Corcia P, Fink JK, Harms MB, Kiernan MC, Delegates of the 2nd International PLS Conference, et al. Primary lateral sclerosis: consensus diagnostic criteria. J Neurol Neurosurg Psychiatry. 2020;91:373–7.
   PubMed Web of Science ®Google Scholar
• Mitsumoto H, Chiuzan C, Gilmore M, Zhang Y, Simmons Z, Paganoni S, PLSFRS study group, et al. Primary lateral sclerosis (PLS) functional rating scale: PLS-specific clinimetric scale. Muscle Nerve. 2020;61:163–72.
   PubMed Web of Science ®Google Scholar
• Finegan E, Chipika RH, Li Hi Shing S, Doherty MA, Hengeveld JC, Vajda A, et al. The clinical and radiological profile of primary lateral sclerosis: a population-based study. J Neurol. 2019;266:2718–33.
   PubMed Web of Science ®Google Scholar
• Finegan E, Li Hi Shing S, Siah WF, Chipika RH, Chang KM, McKenna MC, et al. Evolving diagnostic criteria in primary lateral sclerosis: The clinical and radiological basis of "probable PLS". J Neurol Sci. 2020;417:117052.
   PubMed Web of Science ®Google Scholar
• Genç B, Gautam M, Gözütok Ö, Dervishi I, Sanchez S, Goshu GM, et al. Improving mitochondria and ER stability helps eliminate upper motor neuron degeneration that occurs due to mSOD1 toxicity and TDP-43 pathology. Clin Transl Med. 2021;11:e336.
   PubMed Web of Science ®Google Scholar
• Writing Group. Edaravone ALSSG. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2017;16:505–12.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Berry JD, Ciepielewska M, Liu Y, Zambrano GS, Zhang J, et al. Intravenous daravone treatment in ALS and survival: an exploratory, retrospective, administrative claims analysis. eClinicalMedicine 2022;52:101590.
   PubMedGoogle Scholar
• https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-oral-form-treatment-adults-amyotrophic-lateral-sclerosis-als
   Google Scholar
• Paganoni S, Macklin EA, Hendrix S, Berry JD, Elliott MA, Maiser S, et al. Trial of Sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis. N Engl J Med. 2020;383:919–30.
   PubMed Web of Science ®Google Scholar
• Paganoni S, Hendrix S, Dickson SP, Knowlton N, Macklin EA, Berry JD, et al. Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis. Muscle Nerve. 2021;63:31–9.
   PubMed Web of Science ®Google Scholar
• Paganoni S, Watkins C, Cawson M, Hendrix S, Dickson SP, Knowlton N, et al. Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes. Muscle Nerve. 2022;66:136–41.
   PubMed Web of Science ®Google Scholar
• Paganoni S, De Marchi F, Chan J, Thrower SK, Staff NP, Datta N, NEALS PLS Registry Study Group, et al. The NEALS primary lateral sclerosis registry. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:74–81.
   PubMed Web of Science ®Google Scholar
• Sherman AV, Gubitz AK, Al-Chalabi A, Bedlack R, Berry J, Conwit R, et al. Infrastructure resources for clinical research in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(Suppl 1):53–61.
   PubMedGoogle Scholar
• Thakore NJ, Lapin BR, Pioro EP, Pooled Resource Open-Access Als Clinical Trials Consortium. Stage-specific riluzole effect in amyotrophic lateral sclerosis: a retrospective study. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:140–3.
   PubMed Web of Science ®Google Scholar
• Shefner JM, Al-Chalabi A, Baker MR, Cui L-Y, de Carvalho M, Eisen A, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol. 2020;131:1975–8.
   PubMed Web of Science ®Google Scholar
• Mitsumoto H, Garofalo DC, Gilmore M, Andrews L, Santella RM, Andrews H, et al. Case-control study in ALS using the National ALS Registry: lead and agricultural chemicals are potential risk factors. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:190–202.
   PubMed Web of Science ®Google Scholar
• Pinto S, de Carvalho M. Comparison of slow and forced vital capacities on ability to predict survival in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:528–33.
   PubMed Web of Science ®Google Scholar
• Quinn C, Edmundson C, Dahodwala N, Elman L. Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis. Muscle Nerve. 2020;61:508–11.
   PubMed Web of Science ®Google Scholar
• Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67:206–7.
   PubMed Web of Science ®Google Scholar
• Smith RA, Berg JE, Pope LE, Callahan JD, Wynn D, Thisted RA. Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients. Mult Scler. 2004;10:679–85.
   PubMed Web of Science ®Google Scholar
• Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142–8.
   PubMed Web of Science ®Google Scholar
• Montes J, Cheng B, Diamond B, Doorish C, Mitsumoto H, Gordon PH. The timed up and go test: predicting falls in ALS. Amyotroph Lateral Scler. 2007;8:292–5.
   PubMed Web of Science ®Google Scholar
• Iancu Ferfoglia R, Heritier Barras A-C, Pollak P, Janssens J-P, Pradat P-F, Allali G, et al. Performance and Use of Mental Imagery as a Measure of Disease Progression in Amyotrophic Lateral Sclerosis. Eur Neurol. 2016;75:109–12.
   PubMed Web of Science ®Google Scholar
• Christodoulou G, Gennings C, Hupf J, et al. Telephone based cognitive-behavioral screening for frontotemporal changes in patients with amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler Frontotemporal Degener 2016;28:1–7.
   Google Scholar
• Mitsumoto H, Nagy PL, Gennings C, Murphy M, Andrews H, Goetz R, PLS COSMOS Study Group, et al. Phenotypic and molecular analyses of Primary Lateral Sclerosis (PLS). Neurol Genet. 2015;1:e3.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Highton-Williamson E, Caga J, Matamala JM, Dharmadasa T, Howells J, et al. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum. J Neurol. 2018;265:1819–28.
   PubMed Web of Science ®Google Scholar
• Mitsumoto H, Factor-Litvak P, Andrews H, Goetz RR, Andrews L, Rabkin JG, ALS COSMOS Study Group, et al. ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): Study methodology, recruitment, and baseline demographic and disease characteristics. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:192–203.
   PubMed Web of Science ®Google Scholar
• Andres PL, Thibodeau LM, Finison LJ, Munsat TL. Quantitative assessment of neuromuscular deficit in ALS. Neurol Clin. 1987;5:125–41.
   PubMed Web of Science ®Google Scholar
• Andres PL, Skerry LM, Thornell B, Portney LG, Finison LJ, Munsat TL. A comparison of three measures of disease progression in ALS. J Neurol Sci. 1996;139:64–70.
   PubMed Web of Science ®Google Scholar
• Kent-Braun JA, Walker CH, Weiner MW, Miller RG. Functional significance of upper and lower motor neuron impairment in amyotrophic lateral sclerosis. Muscle Nerve. 1998;21:762–8.
   PubMed Web of Science ®Google Scholar
• Jenkinson C, Fitzpatrick R. Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5. J Neurol Neurosurg Psychiatry. 2001;70:70–3.
   PubMed Web of Science ®Google Scholar
• University N. Health measures: transforming how health is measured 2016. 2016. http://www.healthmeasures.net/explore-measurement-systems/neuro-qol
   Google Scholar
• Cella D, Gershon R, Bass M, Rothrock N. Assessment center. 2013. http://www.assessmentcenter.net/
   Google Scholar
• Gershon RC, Lai JS, Bode R, Choi S, Moy C, Bleck T, et al. Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. Qual Life Res. 2012;21:475–86.
   PubMed Web of Science ®Google Scholar
• Fournier CN, Bedlack R, Quinn C, Russell J, Beckwith D, Kaminski KH, et al. Development and validation of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS). JAMA Neurol. 2020;77:480–8.
   PubMed Web of Science ®Google Scholar
• Mitsumoto H, Kasarskis EJ, Simmons Z. Hastening the diagnosis of amyotrophic lateral sclerosis. Neurology 2022; 99:60–8.
   PubMed Web of Science ®Google Scholar
• Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377:1713–22.
   PubMed Web of Science ®Google Scholar
• Floeter MK, Wu T. Longitudinal evaluation of upper motor neuron burden scales in primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22:23–9.
   PubMed Web of Science ®Google Scholar
• Bedlack RS, Cudkowicz ME. Clinical trials in progressive neurological diseases. Recruitment, enrollment, retention and compliance. Front Neurol Neurosci. 2009;25:144–51.
   PubMedGoogle Scholar
• Hashizume A, Katsuno M, Suzuki K, Hirakawa A, Hijikata Y, Yamada S, et al. Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study. J Neurol Neurosurg Psychiatry. 2017;88:1026–32.
   PubMed Web of Science ®Google Scholar
• Hassan A, Mittal SO, Hu WT, Josephs KA, Sorenson EJ, Ahlskog JE. Does limited EMG denervation in early primary lateral sclerosis predict amyotrophic lateral sclerosis? Amyotroph Lateral Scler Frontotemporal Degener. 2022;23:554–61.
   PubMed Web of Science ®Google Scholar
• Hassan A, Mittal SO, Hu WT, Josephs KA, Sorenson EJ, Ahlskog JE. Natural History of "Pure" Primary Lateral Sclerosis. Neurology 2021;96:e2231–e2238.
   PubMed Web of Science ®Google Scholar
• Rutkove SB, Qi K, Shelton K, Liss J, Berisha V, Shefner JM. ALS longitudinal studies with frequent data collection at home: study design and baseline data. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:61–7.
   PubMed Web of Science ®Google Scholar
• Govindarajan R, Berry JD, Paganoni S, Pulley MT, Simmons Z. Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials. Muscle Nerve. 2020;62:321–6.
   PubMed Web of Science ®Google Scholar
• Pioro EP, Turner MR, Bede P. Neuroimaging in primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:18–27.
   PubMed Web of Science ®Google Scholar